Product News
FDA Not Currently Planning to Hold Advisory Committee Meeting for Burosumab Biologics License Application
Ultragenyx and Kyowa Hakko Kirin announce regulatory review process proceeding as expected; PDUFA date of April 17, 2018
Ultragenyx and Kyowa Hakko Kirin announce regulatory review process proceeding as expected; PDUFA date of April 17, 2018
Learn about the type of controls needed, and when to use controls in oncology assays
Discover application notes, case studies and white papers downloaded daily by analytical scientists
Multiple enhancements in LabVantage 8.3
Panel gives unanimous support to chimeric antigen receptor T cell therapy for acute lymphoblastic leukemia
Visit Thermo Scientific at Booth #3021
Find out how the Extractables and Leachables Service at LGC can help identify and solve problems with drug packaging and delivery